Research Paper Volume 16, Issue 5 pp 4138—4148
Azilsartan improves urinary albumin excretion in hypertension mice
Figure 7. Azilsartan prevents ANG/HS-induced reduction in KLF2 in human renal glomerular endothelial cells (HrGECs). HrGEC monolayer was treated with ANG/HS with or without Azilsartan (2.5, 5 μM) for 24 hours. (A) mRNA level of KLF2; (B) Protein level of KLF2 (n=6, ^^, P<0.01 vs. vehicle group; *, **, P<0.05, 0.01 vs. ANG/HS group).